Publication | Open Access

Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants

ThrombosisTherapeutic Drug MonitoringTherapy MonitoringCoagulation AssaysHematologyPharmacologyAnalytical ChemistryPharmacotherapyDrug MonitoringCoagulopathyClinical ChemistryMedicineAnticoagulantPharmacokineticsChromatographyDrug Analysis